Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy
- Status
- COMPLETED
- Phase
- N/A
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less
- Status
- COMPLETED
- Phase
- N/A
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
- Status
- RECRUITING
- Phase
- PHASE4
Utilization of MAsS in Patients Undergoing LT for HCC
- Status
- TERMINATED
- Phase
- N/A
Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT
- Status
- COMPLETED
- Phase
- PHASE2
Donafenib Plus Sintilimab for Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Y-90 Versus SBRT for Inoperable HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1